BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17396620)

  • 1. Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.
    Hussein RF; Lockyer M; Hammami MM
    Arzneimittelforschung; 2007; 57(2):101-5. PubMed ID: 17396620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioeqivalence assessment of two domperidone 1 tablet formulations.
    Hussein R; Lockyer M; Yusuf A; Al Gaai E; Abdelgaleel A; Hammami MM
    Arzneimittelforschung; 2007; 57(5):269-73. PubMed ID: 17598698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
    Joti JJ; Nahar K; Hasan A; Azad MA; Ullah MA; Islam SM; Hasnat A
    Arzneimittelforschung; 2009; 59(4):171-5. PubMed ID: 19517893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence study of two amoxicillin formulations.
    AlGaai E; AlDigither S; Lockyer M; Hammami MM
    Arzneimittelforschung; 2006; 56(1):48-51. PubMed ID: 16478005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence evaluation of two rosiglitazone tablet formulations.
    Yusuf A; Al-Gaai E; Hammami MM
    Arzneimittelforschung; 2006; 56(11):740-3. PubMed ID: 17220051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioequivalence study of two cetirizine hydrochloride formulations in healthy Chinese male volunteers.
    Xu FG; Liu Y; Zhang ZJ; Tian Y; Chen Y
    Arzneimittelforschung; 2009; 59(9):440-4. PubMed ID: 19856790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence study of two metformin formulations.
    Al Hawari S; AlGaai E; Yusuf A; Abdelgaleel A; Hammami MM
    Arzneimittelforschung; 2007; 57(4):192-5. PubMed ID: 17515289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
    Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
    Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioequivalence study of clindamycin hydrochloride formulations after single-dose administration in healthy Chinese male volunteers.
    Li J; Wang N; Zhang ZJ; Tian Y; Tang W; Chen Y
    Arzneimittelforschung; 2008; 58(7):358-62. PubMed ID: 18751503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers.
    Allegrini A; Nuzzo L; Scaringi AT; Felaco S; Pavone D; Toniato E; Mezzetti A; Martinotti S; Lenotti G
    Arzneimittelforschung; 2008; 58(8):385-8. PubMed ID: 18807578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS 20 mg as tablet encapsulated in a hard gelatine capsule.
    Schaltenbrand R; Huber R; Cotoraci CA; Mascher H; Potthast H; Hole U
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):453-9. PubMed ID: 11680670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence study of two minocycline capsule formulations in healthy volunteers.
    Setiawati E; Purnomo A; Deniati SH; Yunaidi DA; Handayani LR; Harinato G; Santoso ID
    Arzneimittelforschung; 2009; 59(10):532-6. PubMed ID: 19998582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
    Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
    Bonn M; Eydeler U; Barkworth M; Rovati LC
    Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence evaluation of two formulations of fluconazole 150 mg capsule in healthy Arab men.
    Al-Gaai E; Lockyer M; Al-Digither S; Hammami MM
    Biopharm Drug Dispos; 2005 May; 26(4):143-6. PubMed ID: 15776502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsules.
    Amer F; Karol MD; Pan WJ; Griffin JS; Lukasik NL; Locke CS; Chiu YL
    Clin Ther; 2004 Dec; 26(12):2076-83. PubMed ID: 15823771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study.
    Izquierdo I; Borja J; Rovira S; Pelagio P; Torres F; Cebrecos J; García-Rafanell J
    Arzneimittelforschung; 2010; 60(1):36-41. PubMed ID: 20184225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.